Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention. [electronic resource]
Producer: 20030128Description: S19-25 p. digitalISSN:- 1530-6550
- Acute Kidney Injury -- chemically induced
- Aged
- Aged, 80 and over
- Angioplasty, Balloon, Coronary -- adverse effects
- Chi-Square Distribution
- Contrast Media -- adverse effects
- Coronary Angiography -- adverse effects
- Coronary Disease -- diagnostic imaging
- Creatinine -- urine
- Dopamine Agonists -- therapeutic use
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fenoldopam -- therapeutic use
- Follow-Up Studies
- Humans
- Kidney Function Tests
- Male
- Middle Aged
- Probability
- Prospective Studies
- Radiopharmaceuticals -- adverse effects
- Risk Assessment
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.